Liquidity & Capital: Institutional Participation Continues to Broaden across SGX
Institutions net bought Industrials, Real Estate, Telecommunications, Consumer Cyclicals, Technology, Consumer Non-Cyclicals, and Materials &...
183 Views
Primer: iX Biopharma Ltd (IXBIO SP) - Nov 2025
iX Biopharma is a specialty pharmaceutical company centered around its proprietary WaferiX sublingual drug delivery technology, which aims to...
295 Views
Net Institutional Inflow Reversals into Late September
Institutional investors recorded a net outflow of S$336 million across Singapore-listed stocks from 31 August to 25 September. Yangzijiang...
90 Views
LGI Accumulates Shares in Valuetronics & iX Biopharma
Over five sessions, directors reported four acquisitions, substantial shareholders recorded five acquisitions and one disposal for 30...
127 Views
(Non-SGX Report) IX Biopharma Ltd - Wafermine Out-Licensed for C.US$248m
Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...
87 Views
No more insights